Revealing Biological Pathways Implicated in Lung Cancer from TCGA Gene Expression Data using Gene Set Enrichment Analysis. Cancer Informatics Supplement on Cancer Clinical Information Systems

Cai B, Jiang X. Revealing Biological Pathways Implicated in Lung Cancer from TCGA Gene Expression Data using Gene Set Enrichment Analysis. Cancer Inform. 2014 Dec 1;13(Suppl 1):113-21. doi: 10.4137/CIN.S13882. eCollection 2014. PMID: 25520551. PMCID: PMC4251186.

Analyzing biological system abnormalities in cancer patients based on measures of biological entities, such as gene expression levels, is an important and challenging problem. This paper applies existing methods, Gene Set Enrichment Analysis and Signaling Pathway Impact Analysis, to pathway abnormality analysis in lung cancer using microarray gene expression data. Gene expression data from studies of Lung Squamous Cell Carcinoma (LUSC) in The Cancer Genome Atlas project, and pathway gene set data from the Kyoto Encyclopedia of Genes and Genomes were used to analyze the relationship between pathways and phenotypes. Results, in the form of pathway rankings, indicate that some pathways may behave abnormally in LUSC. For example, both the cell cycle and viral carcinogenesis pathways ranked very high in LUSC. Furthermore, some pathways that are known to be associated with cancer, such as the p53 and the PI3K-Akt signal transduction pathways, were found to rank high in LUSC. Other pathways, such as bladder cancer and thyroid cancer pathways, were also ranked high in LUSC.

Publication Year: 
2014
Faculty Author: 
Publication Credits: 
Cai B, Jiang X
Publication Download: 
AttachmentSize
PDF icon revealingbiologicalpathways.pdf741.67 KB
^